Comparison of the Effects of Green Exercise Programs on Metabolic Syndrome Parameters in Elderly Individuals

Not Applicable

• Conditions: Metabolic Syndrome
• Interventions: Other: green exercise with aerobic exercise

• Registration Number: NCT05251597
• Lead Sponsor: Istanbul Medeniyet University

Brief Summary

The aim of this study is to compare the effects of exercise programs that only aerobic exercise and combination aerobic exercise and resistance exercises on the metabolic syndrome parameters in the green exercise concept.

Detailed Description

One hundred twenty volunteer participants aged 65 years over will be included in the study. Participants will be randomly divided into three groups as aerobic, aerobic and resistance and control group. While a group will receive only aerobic exercise, the other group group will receive both aerobic and resistance exercises and one of the group will receive no exercise. Exercises will be held in an open and green area. At the beginning of the treatment and at the end of the twelfth week Hemoglobin A1c (HbA1c), Triglyceride, Hdl cholesterol, Ldl cholesterol, total cholesterol and blood glucose will be evaluated.

Study Timeline

• Study First Submitted: 2021-12-23
• Study First Submitted QC: 2022-02-10
• Study First Posted: 2022-02-22
• Status Verified: 2022-03
• Study Start: 2022-03-27
• Last Update Submitted: 2022-03-28
• Last Update Posted: 2022-03-29
• Primary Completion: 2022-10-08
• Study Completion: 2022-11-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• people aged over 65 years
• Be fit to participate in exercise program after the first cardiac examination by the physician
• Individuals whose blood lipids, Hg a1c and glucose values were checked within 3 months
• According to the International Physical Activity Assessment Questionnaire, those who are physically inactive
• Having a score above 24 in the Minimental Test

Exclusion Criteria

• Having neuromuscular disease
• Serious medical condition (for example, advanced malignancy or major neurological, psychiatric or endocrine disease, respiratory failure, etc.)
• Having an orthopedic disease that interferes with walking
• Having a score below 24 in the Minimental Test

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
green exercise group-1 (aerobic)	green exercise with aerobic exercise	Forty participants who meet the inclusion criteria will first be given warm-up exercises for 10 minutes, then walking at a moderate intensity (65% of heart rate) for 40 minutes and then stretching exercises for 5 minutes
green exercise group-2 (aerobic+resistance)	green exercise with aerobic exercise	For 40 participants who met the inclusion criteria, first 10 minutes of warm-up exercises, then 20 minutes of moderate-intensity (65% of heart rate) walking, followed by 10 minutes of low-intensity (50% of the maximum repetitions) and 10 minutes of high-intensity (80% of the maximum repetitions) resistance exercises will be applied in the presence of a physiotherapist. resistance exercises; shoulder flexors and abductors, elbow flexors and extensors, hip flexors and extensors, knee flexors and extensors, hip abductor muscle group will be performed. At the end of each session, 5 minutes of stretching exercises will also be applied.

Primary Outcome Measures

Name	Time	Method
physical activity level	Change from baseline physical activity level at week 12.	physical activity level will be evaulated with international physical activity questionnairre (IPAQ). The questionnaire is based on calculating the MET (metabolic equivalent) value spent by evaluating at least 10 minutes of physical activity in the last seven days in terms of frequency, duration (minutes) and intensity. According to this questionnaire, physical activity level is categorized into 4 classes: inactive, not active enough, active, very active.
hemoglobin A1c	Change from baseline hemoglobin A1c at week 12.	After 12-14 hr of fasting, a 10 cc blood sample will be collected from each participant. HbA1c will be measured using the Chromatography method with a com-mercial kit .
blood pressure	Change from baseline blood pressure at week 12.	Systolic and diastolic blood pressure will be measured using a standard semi-automatic sphygmomanometer.
lipid profile	Change from baseline lipid profile at week 12.	HDL cholesterol, LDL cholesterol, total cholesterol and triglyceride serum levels will be measured to evaluate the lipid profile.HDL cholesterol, LDL cholesterol, total cholesterol and triglyceride will be assessed using enzymatic colorimetry with commercial kits.
fasting blood glucose	Change from baseline fasting blood glucose at week 12.	After 12-14 hr of fasting, a 10 cc blood sample will be collected from each participant. Fasting blood samples from the antecubital vein will be collected by vacuum tubes. For biochemical analysis, Fasting blood glucose will be assessed with a commercial kit.

Trial Locations

Locations (2)

Emel Mete; 🇹🇷 Istanbul, Turkey

Istanbul Medeniyet University; 🇹🇷 Istanbul, Turkey